Verona Pharma plc buy Truist Financial Co.
Start price
08.01.25
/
50%
€0.51
Target price
08.01.26
€55.32
Performance (%)
-
End price
09.01.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verona Pharma plc | - | - | - |
| iShares Core DAX® | -1.424% | 8.918% | 7.311% |
| iShares Nasdaq 100 | 3.274% | 16.275% | 36.651% |
| iShares Nikkei 225® | 1.745% | 16.239% | 46.602% |
| iShares S&P 500 | 1.447% | 10.913% | 27.166% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Verona Pharma plc diskutieren
Verona Pharma plc (NASDAQ: VRNA) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $57.00 price target on the stock, up previously from $44.00.
Ratings data for VRNA provided by MarketBeat
In the thread Trading Verona Pharma plc
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten